Top 10 Companies in the Chromatography Media for Biopharmaceutical Market (2026): Market Leaders Driving Biopharma Purification

MARKET INSIGHTS

Global chromatography media for biopharmaceutical market size was valued at USD 3.45 billion in 2024. The market is projected to grow from USD 3.78 billion in 2025 to USD 6.91 billion by 2032, exhibiting a CAGR of 8.7% during the forecast period.

Chromatography media are critical materials used in the purification of biopharmaceuticals, enabling the separation of target biomolecules like proteins from complex mixtures. These media include various types such as hydrophobic interaction, ion exchange, affinity, and size exclusion chromatography resins, each designed for specific purification needs. The growing demand for monoclonal antibodies, vaccines, and recombinant proteins is a key driver for this market.

While the market is expanding rapidly due to increased biopharmaceutical production and R&D investments, challenges such as high costs and stringent regulatory requirements persist. Furthermore, advancements in single‑use chromatography systems and continuous bioprocessing are reshaping industry dynamics. Leading players like GE Healthcare, Thermo Fisher Scientific, and Bio‑Rad are innovating to improve resin capacity and selectivity, which is expected to further accelerate market growth.

Chromatography Media for Biopharmaceutical Market – View in Detailed Research Report

Top 10 Companies in the Chromatography Media for Biopharmaceutical Market (2026)

1. Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA
Key Offering: ÄKTA chromatography systems, Protein A resins, ion‑exchange media

Thermo Fisher’s portfolio spans from laboratory‑scale to large‑scale commercial purification, positioning it as a one‑stop solution for biopharmaceutical developers. The company’s recent investments in high‑throughput resin screening and automated process analytics have shortened development timelines and lowered capital expenditures for clients.

Sustainability & Growth Initiatives:

• Launch of recyclable single‑use resin cartridges
• Expansion of the Global Bioprocessing Hub in Singapore
• Investment in AI‑driven purification design tools

2. Cytiva

Headquarters: Limerick, Ireland
Key Offering: Protein A media, multimodal resins, scalable chromatography systems

Formerly GE Healthcare, Cytiva’s deep heritage in affinity chromatography underpins its leadership in antibody capture. Recent product lines feature ultra‑high binding capacity resins that reduce the number of chromatography steps, thereby enhancing overall yield.

Sustainability & Growth Initiatives:

• Carbon‑neutral manufacturing of resins by 2030
• Partnerships with academic labs for next‑generation ligand development
• Rollout of pre‑packed columns in emerging markets

3. Tosoh

Headquarters: Tokyo, Japan
Key Offering: Hydrophobic interaction resins, ion‑exchange media, membrane chromatography

Tosoh’s expertise in multimodal ligands has positioned it as a preferred supplier for complex biologic purifications. The company’s recent launch of a high‑capacity HIC resin set caters to the rising demand for antibody‑drug conjugates.

Sustainability & Growth Initiatives:

• Implementation of water‑recycling processes in resin manufacturing
• Expansion of the Asia‑Pacific production facility
• Development of biodegradable resin supports

4. Bio‑Rad Laboratories

Headquarters: Hercules, California, USA
Key Offering: Affinity resins, protein purification kits, analytical instruments

Bio‑Rad’s integration of chromatography media with its analytical platform allows clients to perform end‑to‑end purification and quality control in a single workflow, reducing batch turnaround times.

Sustainability & Growth Initiatives:

• Launch of low‑water‑usage resin manufacturing line
• Collaborations with biotech startups for rapid prototyping
• Investment in digital process monitoring solutions

5. Sartorius AG

Headquarters: Göttingen, Germany
Key Offering: Bulk resins, pre‑packed columns, process analytical technology

Sartorius’s focus on process analytics complements its chromatography media, enabling real‑time monitoring of purity and yield. The company’s recent launch of a modular chromatography system targets small‑to‑medium enterprises seeking scalable solutions.

Sustainability & Growth Initiatives:

• Carbon‑offset program for resin production
• Development of reusable column housings
• Expansion of the European R&D hub

6. Agilent Technologies

Headquarters: Santa Clara, California, USA
Key Offering: Size‑exclusion resins, multimodal media, chromatography instrumentation

Agilent’s dual strength in analytical instrumentation and media manufacturing allows seamless integration of purification and quality control, a critical advantage for contract manufacturers.

Sustainability & Growth Initiatives:

• Energy‑efficient resin synthesis processes
• Partnerships with universities for ligand discovery
• Launch of a cloud‑based chromatography data platform

7. Mitsubishi Chemical Group

Headquarters: Tokyo, Japan
Key Offering: Affinity and ion‑exchange resins, single‑use systems, process solutions

Through its Finesse bioprocess division, Mitsubishi Chemical supplies high‑performance resins tailored for continuous manufacturing, aligning with industry trends toward process intensification.

Sustainability & Growth Initiatives:

• Reduction of chemical waste in resin production
• Expansion of the China manufacturing footprint
• Research into bio‑based ligand chemistries

8. Sunresin New Materials Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Affinity resins, ion‑exchange media, cost‑effective single‑use cartridges

Sunresin’s focus on affordable, high‑quality media has positioned it as a preferred supplier in emerging markets, supporting the rapid growth of biopharmaceutical manufacturing in China.

Sustainability & Growth Initiatives:

• Implementation of green chemistry principles in resin synthesis
• Local sourcing of raw materials to reduce carbon footprint
• Collaboration with regional CMOs to accelerate adoption

9. Suzhou Nanomicro Technology

Headquarters: Suzhou, China
Key Offering: High‑capacity ion‑exchange resins, multimodal media, pre‑packed columns

Nanomicro’s emphasis on scalable production and rapid turnaround has made it a go‑to partner for companies expanding into gene therapy and cell‑based products.

Sustainability & Growth Initiatives:

• Energy‑saving manufacturing protocols
• Development of biodegradable column supports
• Investment in digital supply chain transparency

10. Sepax Technologies, Inc.

Headquarters: Irvine, California, USA
Key Offering: Pre‑packed chromatography columns, automated purification systems, single‑use solutions

Sepax’s automated, pre‑packed platforms reduce the risk of user error and accelerate time‑to‑market for new biologics. The company’s recent launch of a modular, single‑use system caters to the needs of small biotechs.

Sustainability & Growth Initiatives:

• Zero‑waste manufacturing of column housings
• Partnerships with green chemistry research groups
• Expansion of the North American production line

Download FREE Sample Report

Get Full Report

Outlook

The trajectory of the chromatography media market is tightly linked to the pace of biologics development. As the pipeline for mAbs, gene therapies, and advanced therapy medicinal products expands, the demand for high‑throughput, high‑purity purification solutions will continue to rise. Companies that can deliver scalable, cost‑effective media while meeting evolving regulatory expectations will secure a competitive edge.

Future Trends

• Single‑use chromatography systems that reduce cross‑contamination and validation burden.
• Continuous bioprocessing platforms that integrate upstream and downstream steps.
• Multimodal and mixed‑mode resins offering simultaneous removal of multiple impurity classes.
• Digitalization of purification workflows, enabling real‑time data capture and predictive analytics.
• Focus on sustainability, with recyclable resins and reduced water consumption.